These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 16513476)

  • 1. Role of tissue kallikrein-kininogen-kinin pathways in the cardiovascular system.
    Sharma JN
    Arch Med Res; 2006 Apr; 37(3):299-306. PubMed ID: 16513476
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Does the kinin system mediate in cardiovascular abnormalities? An overview.
    Sharma JN
    J Clin Pharmacol; 2003 Nov; 43(11):1187-95. PubMed ID: 14551172
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cardiovascular activities of the bradykinin system.
    Sharma JN
    ScientificWorldJournal; 2008 Apr; 8():384-93. PubMed ID: 18454246
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Kallikrein-kinin in stroke, cardiovascular and renal disease.
    Chao J; Chao L
    Exp Physiol; 2005 May; 90(3):291-8. PubMed ID: 15653716
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The kinin system in hypertensive pathophysiology.
    Sharma JN
    Inflammopharmacology; 2013 Feb; 21(1):1-9. PubMed ID: 22527353
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Therapeutic prospects for bradykinin receptor agonists in the treatment of cardiovascular diseases.
    Sharma JN; Thani RB
    IDrugs; 2004 Oct; 7(10):926-34. PubMed ID: 15478018
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The plasma and tissue kininogen-kallikrein-kinin system: role in the cardiovascular system.
    Marcondes S; Antunes E
    Curr Med Chem Cardiovasc Hematol Agents; 2005 Jan; 3(1):33-44. PubMed ID: 15638742
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cardiovascular properties of the kallikrein-kinin system.
    Sharma JN; Sharma J
    Curr Med Res Opin; 2002; 18(1):10-7. PubMed ID: 11999140
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The kallikrein-kinin pathways in hypertension and diabetes.
    Sharma JN; Narayanan P
    Prog Drug Res; 2014; 69():15-36. PubMed ID: 25130038
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The tissue kallikrein-kinin system protects against cardiovascular and renal diseases and ischemic stroke independently of blood pressure reduction.
    Chao J; Bledsoe G; Yin H; Chao L
    Biol Chem; 2006 Jun; 387(6):665-75. PubMed ID: 16800727
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Visualisation of tissue kallikrein, kininogen and kinin receptors in human skin following trauma and in dermal diseases.
    Schremmer-Danninger E; Naidoo S; Neuhof C; Valeske K; Snyman C; Sander C; Bhoola KD; Neuhof H
    Biol Chem; 2004 Nov; 385(11):1069-76. PubMed ID: 15576327
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cardioprotection and kallikrein-kinin system in acute myocardial ischaemia in mice.
    Messadi-Laribi E; Griol-Charhbili V; Gaies E; Vincent MP; Heudes D; Meneton P; Alhenc-Gelas F; Richer C
    Clin Exp Pharmacol Physiol; 2008 Apr; 35(4):489-93. PubMed ID: 18307747
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Attenuated kinin release from human neutrophil elastase-pretreated kininogens by tissue and plasma kallikreins.
    Dulinski R; Suder P; Guevara-Lora I; Rapała-Kozik M; Potempa J; Silberring J; Imamura T; Travis J; Kozik A
    Biol Chem; 2003 Jun; 384(6):929-37. PubMed ID: 12887060
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tissue kallikrein in cardiovascular, cerebrovascular and renal diseases and skin wound healing.
    Chao J; Shen B; Gao L; Xia CF; Bledsoe G; Chao L
    Biol Chem; 2010 Apr; 391(4):345-55. PubMed ID: 20180644
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Release of endothelial-derived kallikrein, kininogen and kinins.
    Nolly H; Nolly A
    Biol Res; 1998; 31(3):169-74. PubMed ID: 9830504
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The kininogen gene family in obstructive uropathy.
    El-Dahr SS
    Semin Nephrol; 1998 Nov; 18(6):633-40. PubMed ID: 9819154
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tissue kallikrein-kinin therapy in hypertension and organ damage.
    Chao J; Bledsoe G; Chao L
    Prog Drug Res; 2014; 69():37-57. PubMed ID: 25130039
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New perspective on the tissue kallikrein-kinin system in myocardial infarction: role of angiogenesis and cardiac regeneration.
    Westermann D; Schultheiss HP; Tschöpe C
    Int Immunopharmacol; 2008 Feb; 8(2):148-54. PubMed ID: 18182218
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Contribution of kinins to the cardiovascular actions of angiotensin-converting enzyme inhibitors.
    Linz W; Wiemer G; Gohlke P; Unger T; Schölkens BA
    Pharmacol Rev; 1995 Mar; 47(1):25-49. PubMed ID: 7784479
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The kallikrein-kinin system as a regulator of cardiovascular and renal function.
    Rhaleb NE; Yang XP; Carretero OA
    Compr Physiol; 2011 Apr; 1(2):971-93. PubMed ID: 23737209
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.